Triple
T4784886
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Merck & Co. |
E106451
|
entity |
| Predicate | notableDrug |
P7501
|
FINISHED |
| Object |
Keytruda
Keytruda is a widely used immunotherapy cancer drug (pembrolizumab) that works by blocking the PD-1 pathway to help the immune system attack tumors.
|
E468955
|
NE FINISHED |
Provenance (6 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69bd43f4a9588190bf73e20bc27c03cc |
elicitation | completed |
| NER | batch_69bd65ae49ec81908f16248d22d1155f |
ner | completed |
| NED1 | batch_69be43dbdec88190817845e7930a18f6 |
ned_source_triple | completed |
| NED2 | batch_69be45f5ebec8190b62c428b465d1bd9 |
ned_description | completed |
| NEDg | batch_69be447c21d48190ab57c8761e733ff4 |
nedg | completed |
| PD | batch_69bd622e1b408190806c15c61519fc74 |
pd | completed |
Created at: March 20, 2026, 1:22 p.m.